First Light Adds New Multimedia to Website
New videos include 1-1 clinician interviews and detailed product tour Chelmsford, MA – (July 10th, 2019) First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced the introduction of new multimedia content on the homepage of the First Light Diagnostics website. The new content…
First Light Diagnostics Announces Closing of a $4.5 million Debt Financing
Additional funds to support the company’s diagnostic platform initiatives Chelmsford, MA – (June 19, 2019) – First Light Diagnostics, Inc., a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis and treatment of life-threatening, antibiotic-resistant infections, today announced the closing of a $4.5 million debt financing. This includes a Lease Line with CSC…
First Light Diagnostics to Showcase MultiPath™ Platform at ASM Microbe 2019
CHELMSFORD, Mass., June 6, 2019 (Newswire.com) – First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced its participation at the American Society for Microbiology’s ASM Microbe 2019 Event in San Francisco, California, from June 20-24. First Light Diagnostics will be exhibiting in the Innovation Zone, the newest addition…
First Light Diagnostics Recognized by Frost & Sullivan as Technology Innovation Leader
First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced it has been recognized by Frost & Sullivan for best practices in Technology Innovation in the Rapid Diagnostics Industry. Frost & Sullivan, the Growth Partnership Company, collaborates with clients to leverage visionary innovation that…
Dr. Stephen Brecher Joins First Light Diagnostics Clinical Advisory Board
Chelmsford, MA (March 13th, 2019) – First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced the addition of Dr. Stephen Brecher to the company’s world-class, international Clinical Advisory Board. “Stephen is an internationally recognized expert for his work with C. difficile infections and…
First Light Diagnostics Forms World-Class International Clinical Advisory Board
Industry Experts to Support Development and Commercialization Chelmsford, MA (Newswire.com) – First Light Diagnostics, Inc., a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced the establishment of a Clinical Advisory Board (CAB). The board is a growing list of members asked to participate based on world-renowned expertise…
Dr. Peter Kaspar Joins First Light Diagnostics Board of Directors
Chelmsford, MA, February 6, 2019 (Newswire.com) – First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced the addition of Dr. Peter Kaspar to the company’s board of directors effective January 1, 2019. “Peter is one of the most respected executives in life sciences and…
First Light Diagnostics Invited to Speak at Boston Area Antibiotic Resistance Network
Company Presents New Method for Rapidly Determining the Effective Antibiotics to Treat Serious Infections Directly from Patient Samples Chelmsford, Massachusetts, January 24, 2019 (Newswire.com) – First Light Diagnostics, a developer of breakthrough automated diagnostic products for rapid, sensitive, and cost-effective diagnostic tests for life-threatening infections, today announced their recent participation at the 6th Annual Meeting of the…
First Light Diagnostics Closes $8.25 Million Series A-2 Financing
First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced it has closed an oversubscribed $8.25 million Series A-2 financing. The financing includes new investment partners from Think.Health Ventures, 10x Group, and Beacon Angels, along with numerous new individual investors and continued participation from…
First Light Announces Company Name Change
Chelmsford, MA – January 7, 2019 — First Light Biosciences, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening antibiotic-resistant infections, today announced that effective immediately, the company is changing their name to First Light Diagnostics. The new name reflects the company’s evolution from development to commercialization of diagnostic solutions….